ExCITE

ExCITE

University of Louisville ExCITE


 

The purpose of the NIH Research Evaluation and Commercialization Hub (REACH) is to support proof-of-concept centers (hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health.The long-term goals of the program are to foster commercialization success, economic development and entrepreneurial culture change at each hub institution.

The University of Louisville ExCITE program, developed by co-principal investigators Dr. Paula Bates, Dr. Eugene Krentsel & Dr. Donald Miller, administers support by developing infrastructure for identifying technologies, allocating funding for product definition studies, providing access to early-stage development expertise and offering hands-on skills development in entrepreneurism.


 

The ExCITE Team

 

 

Paula Bates

Paula Bates, PhD
Contact Principal Investigator
Department of Medicine
Expertise: Drug Development, Mechanistic Studies
Email Paula Bates

Donald Miller

Donald M. Miller, MD, PhD
Co-Principal Investigator
Director, James Graham Brown Cancer Center
Expertise: Drug Development, Clinical Oncology
Email Donald Miller

Christopher Barton

Christopher L. Barton, JD, PhD
Technology Manager, Technology Transfer
Office of Technology Transfer
Expertise: Technology Evaluation and Transfer
Email Christopher Barton

J. Brad Chaires

J. Brad Chaires, PhD
Co-Investigator
Department of Medicine
Expertise: Biophysics, Devices, Diagnostics
Email J. Brad Chaires

Holly Clark

Holly Symonds Clark, PhD
Deputy Director, Technology Transfer
Office of Technology Transfer
Expertise: Technology Transfer, Education
Email Holly Symonds Clark

Matthew Hawthorne

Matthew J. Hawthorne, JD, MBA
Director, Industry Engagement
Office of Industry Engagement
Expertise: Tech Transfer, Industry Engagement, Education
Email Matthew Hawthorne

Kenneth Palmer

Kenneth E. Palmer, PhD
Co-Investigator
Department of Pharmacology & Toxicology
Expertise: Vaccines, Peptides, Plant-based Drugs
Email Kenneth Palmer

Eugene Krentsel

Eugene B. Krentsel, PhD
Co-Principal Investigator
Associate VP for Research & Innovation
Expertise: Entrepreneurship, Technology Transfer
Email Eugene Krentsel

Sarah Andres

Sarah Andres, PhD
Scientific Coordinator
Cancer Center
Expertise: Drug Development, Mechanistic Studies
Email Sarah Andres

Rebecca Brown

Rebecca Brown
ExCITE Program Manager
EVPRI
Expertise: Neuroscience, Programming
Email Rebecca Brown

Jason Chesney

Jason A. Chesney, MD, PhD
Co-Investigator
Department of Medicine
Expertise: Preclinical Studies, Clinical Oncology
Email Jason Chesney

John Eaton

John W. Eaton, PhD
Co-Investigator
Department of Medicine
Expertise: Cell-based Therapies, Devices
Email John Eaton

Robert Keynton

Robert S. Keynton, PhD
Co-Investigator
Department of Bioengineering
Expertise: Nanotechnology, Devices
Email Robert Keynton

Allen Morris

T. Allen Morris, PhD
Director, Technology Transfer
Office of Technology Transfer
Expertise: Technology Transfer, Education
Email Allen Morris

John Trent

John O. Trent, PhD
Co-Investigator
Department of Medicine
Expertise: Drug Development, Small Molecules
Email John Trent

 

 

 

Funding

 

 

ExCITE will offer grant opportunities (up to $200,000 per grant). These grants are open to any University of Louisville faculty, staff, and students for all human health-related technology types. The technologies must originate from the University of Louisville and be eligible for intellectual property protection (or have some other potential to return income to the program). There is no disease-specific requirement, but each application/proposal will be reviewed carefully for technical consistency and other criteria before funding is determined.

Applicants can request funding for anything that will make the technology more attractive to the private sector, including specific development studies that have been requested by potential investors, licensees or partners.

For a therapeutics example, this could be (but is not limited to) any of the following: medicinal chemistry optimization of a lead compound, in-vivo efficacy studies if there is strong in vitro data, initial pharmacology and toxicology if in vivo proof-of-concept has been shown, proof of mechanism if in vivo efficacy has been demonstrated, validation in additional or better in vivo models, drug discovery if an exceptional new target with an available screen and/or validation models is discovered, and any other activities that are not usually covered by traditional grants, such IP analysis, market research, business plan development, consulting with industry experts, clinical trial design, product scale-up, GMP manufacturing, formulation, or independent verification of reproducibility.


 

 

Application Process and FAQs

ExCITE Cycle #6 Request for applications and instructions

ExCITE Cycle #6 Application, Part 1: Non-proprietary Abstract Form

Cycle #6 Application, Part 2: Application Forms

 

 

 


 

Announcements

Belknap ExCITE Cycle #5 Information Session:  Tuesday, February 7th, 11:00am-12:00pm, Shumaker Research Building, Room 139 

HSC ExCITE Cycle #5 Information Session: Tuesday, February 7th, 2:00pm-3:00pm, Clinical Translational Research Building (CTRB) Room 123 

Fall Trifecta Training Series starts September 20th, 2016

7.21.2016 - Belknap ExCITE Cycle #4 Information Session

7.21.2016 - HSC ExCITE Cycle #4 Information Session

2.16.2016 - HSC ExCITE Cycle #3 Informational Session

2.16.2016 - Belknap ExCITE Cycle #3 Informational Session

10.13.2015 - Life Science Business Training Modules by UofL ExCITE, Coulter Translational Partnership and I-Corps: Module 5 - Starting a Small Company for a Life-Science Technology

10.13.2015 - WEBINAR: How Pharma Evaluates New Therapeutic Opportunities

10.06.2015 - Life Science Business Training Modules by UofL ExCITE, Coulter Translational Partnership and I-Corps: Module 4 - Pathways to Commercialization

9.29.2015 - Life Science Business Training Modules by UofL ExCITE, Coulter Translational Partnership and I-Corps: Module 3 - Product Development of a Life-Science Technology

9.22.2015 - Life Science Business Training Modules by UofL ExCITE, Coulter Translational Partnership and I-Corps: Module 2 - Building a Compelling Product Story

9.15.2015 - Life Science Business Training Modules by UofL ExCITE, Coulter Translational Partnership and I-Corps: Module 1 - Introduction to Life-Science Tract Training and Focus on Technology

8.19.2015 - ExCITE Cycle 2 Grant Informational (Health Sciences Campus)

8.18.2015 - ExCITE Cycle 2 Grant Informational (Belknap Campus)

8.06.2015 - UofL hosting informational for *new* KSTC Funding Opportunity

7.16.2015 - Inaugural ExCITE Bootcamp

5.13.2015 -WEBINAR: Connecting CTSA Researchers with SBIR/STTR Dollars - Could an SBIR/STTR award be right for you?

4.23.2015 - UofL awarded $3 million to speed technologies to market (UL Today)

4.22.2015 -UofL awarded $3 million to speed technologies to market (Lane Report)

3.25.2015 -NIH selects 3 'hubs' to speed medical technology development in REACH program

3.23.2015 -NIH Selects Awardees To Help Speed Development Of Health Technologies

3.23.2015 -NIH selects awardees to help speed development of health technologies (NIH)

 


For Additional Information:

Email the ExCITE staff